Advanced Biomed Acquires AI Firm, Names Acellent Founder as New CEO
Advanced Biomed Inc. completed its acquisition of Acellent Technologies (Hong Kong) Co. Limited on April 30, issuing 270,000 shares valued at $1.08 million to Xiaomin Chen, Acellent's founder and sole shareholder. The deal marks the company's formal shift from life sciences to artificial intelligence development.
Chen, 49, takes over as chief executive, director, and chairman effective April 28. He replaces Yi Lu, who departed in a mutual separation and received 39,999 shares as severance. Lu's exit was tied directly to the strategic pivot, with the company determining that new leadership was necessary for the transition.
New CEO's Background
Chen brings two decades of experience in AI and large language models. At Acellent since 2019, he led development of FinLLM, a financial-domain large language model, and FinTruth, a system designed to verify AI outputs for compliance and explainability in regulated markets.
Before founding Acellent, Chen spent nine years at Google as a software engineer on the Core Search and AI team, earning the company's annual outstanding contribution award in 2009 for work on AI-powered indexing and storage optimization. From 2010 to 2019, he served as chief technology officer at Shanghai Jianshi Network Technology, where he built an AI-powered image search platform.
Chen holds a Ph.D. in computer science from Rutgers University and a bachelor's degree from Shanghai Jiao Tong University.
Compensation and Structure
Chen's employment agreement sets his compensation at $12,000 per month. The acquisition shares he received as part of the deal represent his interest in the transaction as the seller of Acellent's equity.
Advanced Biomed issued the acquisition shares under Section 4(a)(2) of the Securities Act, an exemption for private placements. The company filed the transaction details in a Form 8-K with the SEC on May 1.
For executives evaluating strategic pivots and leadership transitions, this move illustrates how acquisitions can anchor a shift into new markets. Learn more about AI strategy for executives to understand how organizations are structuring similar transitions.
Your membership also unlocks:
